FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

425508009: Sitagliptin phosphate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661573010 Sitagliptin phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675154010 Sitagliptin phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
897231000052118 sitagliptinfosfat sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sitagliptin phosphate (substance) Is a Sitagliptin (substance) false Inferred relationship Some
Sitagliptin phosphate (substance) Has disposition (attribute) Dipeptidyl peptidase IV inhibitor (disposition) true Inferred relationship Some
Sitagliptin phosphate (substance) Is modification of (attribute) Sitagliptin (substance) true Inferred relationship Some
Sitagliptin phosphate (substance) Is a Dipeptidyl peptidase IV inhibitor true Inferred relationship Some
Sitagliptin phosphate (substance) Is a Triazole derivative (substance) true Inferred relationship Some
Sitagliptin phosphate (substance) Is a Serine proteinase inhibitor true Inferred relationship Some
Sitagliptin phosphate (substance) Has disposition (attribute) Serine proteinase inhibitor (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some
Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some
Product containing metformin and sitagliptin (medicinal product) Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some 1
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Sitagliptin phosphate (substance) Inferred relationship Some 2
Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet Has active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some 2
Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet Has basis of strength substance (attribute) True Sitagliptin phosphate (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Sitagliptin phosphate (substance) Inferred relationship Some 1
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Some 1
Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Some 2
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Some 1
Sitagliptin phosphate monohydrate (substance) Is modification of (attribute) True Sitagliptin phosphate (substance) Inferred relationship Some
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start